Pursuing breakthroughs that will change how cancer is treated forever
Cancer is a complex disease with hundreds of variations and an ability to adapt and evolve. It’s critical that we fund the development of groundbreaking clinical trials that The Royal Marsden can rapidly translate into improved outcomes, quicker recovery times and a better quality of life for its patients.
Pioneering research is absolutely critical to extending, improving and saving the lives of more people diagnosed with cancer. That’s why we’re dedicated to helping run life-saving clinical trials that give patients at the hospital, across the UK and around the world access to the latest breakthrough drugs.
How we are funding research
Through the five year, £15 million grant to support translational research at The Royal Marsden, we have funded work in the West Wing Clinical Research Centre, where patients on clinical trials are treated in a custom-built setting with dedicated research staff. We also continued to fund specialist staff working in the Biobank at the National Institute for Health Research Centre for Molecular Pathology, a facility that is invaluable to research and the future of personalised treatment.
We are funding four research fellows, through the Le Cure fundraising campaign, who are making a real difference to the treatment of breast cancer patients through molecular diagnostics.
Support our work
We can only continue to do this ground breaking research with the generous donations from our supporters. Help us to support more live saving research.
We deliver new clinical trials to patients across all tumour types. What drives us is the sense of hope the unit brings. Our patients come from across the country to enter clinical trials, and the fact that we can give them that chance is what sets us apart.